Amgen vs. Novo Nordisk: Which Healthcare Giant's Stock Is a Better Buy in 2026?
Key PointsAmgen maintains a robust presence in oncology and rare diseases with a 9.9% revenue growth rate in FY 2025.
Key PointsAmgen maintains a robust presence in oncology and rare diseases with a 9.9% revenue growth rate in FY 2025.